Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Browse Other Projects on Experiment
Related Projects
Community-based Leishmaniasis research in Sri Lanka
Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...
From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation
This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...